Logo image of KRY.CA

KORYX COPPER INC (KRY.CA) Stock Fundamental Analysis

TSX-V:KRY - TSX Venture Exchange - CA50067J2020 - Common Stock - Currency: CAD

1.2  +0.03 (+2.56%)

Fundamental Rating

3

Overall KRY gets a fundamental rating of 3 out of 10. We evaluated KRY against 822 industry peers in the Metals & Mining industry. No worries on liquidiy or solvency for KRY as it has an excellent financial health rating, but there are worries on the profitability. KRY is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year KRY has reported negative net income.
In the past year KRY has reported a negative cash flow from operations.
In the past 5 years KRY always reported negative net income.
In the past 5 years KRY always reported negative operating cash flow.
KRY.CA Yearly Net Income VS EBIT VS OCF VS FCFKRY.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M

1.2 Ratios

KRY has a Return On Assets of -142.73%. This is in the lower half of the industry: KRY underperforms 76.97% of its industry peers.
KRY has a Return On Equity of -152.35%. This is in the lower half of the industry: KRY underperforms 68.24% of its industry peers.
Industry RankSector Rank
ROA -142.73%
ROE -152.35%
ROIC N/A
ROA(3y)-611.58%
ROA(5y)-377.83%
ROE(3y)-857.09%
ROE(5y)-526.52%
ROIC(3y)N/A
ROIC(5y)N/A
KRY.CA Yearly ROA, ROE, ROICKRY.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K

1.3 Margins

KRY does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KRY.CA Yearly Profit, Operating, Gross MarginsKRY.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

9

2. Health

2.1 Basic Checks

The number of shares outstanding for KRY has been increased compared to 1 year ago.
Compared to 5 years ago, KRY has less shares outstanding
There is no outstanding debt for KRY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
KRY.CA Yearly Shares OutstandingKRY.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
KRY.CA Yearly Total Debt VS Total AssetsKRY.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

KRY has an Altman-Z score of 265.33. This indicates that KRY is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of KRY (265.33) is better than 98.55% of its industry peers.
KRY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 265.33
ROIC/WACCN/A
WACCN/A
KRY.CA Yearly LT Debt VS Equity VS FCFKRY.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M 8M

2.3 Liquidity

KRY has a Current Ratio of 14.62. This indicates that KRY is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 14.62, KRY belongs to the best of the industry, outperforming 89.94% of the companies in the same industry.
KRY has a Quick Ratio of 14.62. This indicates that KRY is financially healthy and has no problem in meeting its short term obligations.
KRY has a better Quick ratio (14.62) than 89.94% of its industry peers.
Industry RankSector Rank
Current Ratio 14.62
Quick Ratio 14.62
KRY.CA Yearly Current Assets VS Current LiabilitesKRY.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for KRY have decreased strongly by -406.04% in the last year.
EPS 1Y (TTM)-406.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-458.62%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

KRY is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -57.95% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-162.7%
EPS Next 2Y-98.51%
EPS Next 3Y-57.95%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KRY.CA Yearly Revenue VS EstimatesKRY.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
KRY.CA Yearly EPS VS EstimatesKRY.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -0.1 -0.2 -0.3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for KRY. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for KRY. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KRY.CA Price Earnings VS Forward Price EarningsKRY.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KRY.CA Per share dataKRY.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.05 -0.1 -0.15 -0.2

4.3 Compensation for Growth

KRY's earnings are expected to decrease with -57.95% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-98.51%
EPS Next 3Y-57.95%

More info and screens

0

5. Dividend

5.1 Amount

KRY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KORYX COPPER INC

TSX-V:KRY (3/7/2025, 7:00:00 PM)

1.2

+0.03 (+2.56%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)12-17 2024-12-17
Earnings (Next)N/A N/A
Inst Owners7.52%
Inst Owner ChangeN/A
Ins Owners2.5%
Ins Owner ChangeN/A
Market Cap83.63M
Analysts84
Price Target3.72 (210%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.95%
PT rev (3m)-13.1%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 31.32
P/tB 31.32
EV/EBITDA N/A
EPS(TTM)-0.09
EYN/A
EPS(NY)-0.25
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0
BVpS0.04
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -142.73%
ROE -152.35%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-611.58%
ROA(5y)-377.83%
ROE(3y)-857.09%
ROE(5y)-526.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 792.97%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 14.62
Quick Ratio 14.62
Altman-Z 265.33
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)69137.9%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-406.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-458.62%
EPS Next Y-162.7%
EPS Next 2Y-98.51%
EPS Next 3Y-57.95%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-187.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-77.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-108.93%
OCF growth 3YN/A
OCF growth 5YN/A